Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Shares Outstanding (Weighted Average): 2018-2024

Historic Shares Outstanding (Weighted Average) for Genmab A (GMAB) over the last 7 years, with Dec 2024 value amounting to $66.2 million.

  • Genmab A's Shares Outstanding (Weighted Average) rose 0.72% to $65.5 million in Q2 2021 from the same period last year, while for Dec 2020 it was $65.1 million, marking a year-over-year change of. This contributed to the annual value of $66.2 million for FY2024, which is 0.17% up from last year.
  • Latest data reveals that Genmab A reported Shares Outstanding (Weighted Average) of $66.2 million as of FY2024, which was up 0.17% from $66.1 million recorded in FY2023.
  • In the past 5 years, Genmab A's Shares Outstanding (Weighted Average) ranged from a high of $66.2 million in FY2024 and a low of $65.1 million during FY2020.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $66.0 million, with a median of $66.1 million in 2023.
  • Data for Genmab A's Shares Outstanding (Weighted Average) shows a peak YoY grew of 1.20% (in 2020) over the last 5 years.
  • Yearly analysis of 5 years shows Genmab A's Shares Outstanding (Weighted Average) stood at $65.1 million in 2020, then increased by 0.84% to $65.6 million in 2021, then rose by 0.32% to $65.8 million in 2022, then grew by 0.36% to $66.1 million in 2023, then climbed by 0.17% to $66.2 million in 2024.